Literature DB >> 30604369

Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.

Jingwei Liu1, Hao Li1, Liping Sun1, Shixuan Shen1, Quan Zhou1, Yuan Yuan2, Chengzhong Xing3.   

Abstract

BACKGROUND: Liver metastasis is a major cause of mortality in colorectal cancer (CRC). Epigenetic alternations could serve as biomarkers for cancer diagnosis and prognosis. In this study, we analyzed microarray data in order to identify core genes and pathways which contribute to liver metastasis in CRC under epigenetic regulations.
MATERIALS AND METHODS: Data of miRNAs (GSE35834, GSE81582), DNA methylation (GSE90709, GSE77955), and mRNA microarrays (GSE68468, GSE81558) were downloaded from GEO database. Differentially expressed genes (DEGs), differentially expressed miRNAs (DEMs), and differentially methylated genes (DMGs) were obtained by GEO2R. The target genes of DEMs were predicted by miRWalk. Functional and enrichment analyses were conducted by DAVID database. Protein-protein interaction (PPI) network was constructed in STRING and visualized using Cytoscape.
RESULTS: In liver metastasis, miR-143-3p, miR-10b-5p, miR-21-5p, and miR-518f-5p were down-regulated, while miR-122-5p, miR-885-5p, miR-210-3p, miR-130b-5p, miR-1275, miR-139-5p, miR-139-3p, and miR-1290 were up-regulated compared with primary CRC. DEGs targeted by altered miRNAs were enriched in pathways including complement, PPAR signaling, ECM-receptor interaction, spliceosome, and focal adhesion. In addition, aberrant DNA methylation-regulated genes showed enrichment in pathways of amino acid metabolism, calcium signaling, TGF-beta signaling, cell cycle, spliceosome, and Wnt signaling.
CONCLUSION: Our study identified a series of differentially expressed genes which are associated with epigenetic alternations of miRNAs and DNA methylation in colorectal liver metastasis. Up-regulated genes of SLC10A1, MAPT, SHANK2, PTH1R, and C2, as well as down-regulated genes of CAB39, CFLAR, CTSC, THBS1, and TRAPPC3 were associated with both miRNA and DNA methylation, which might become promising biomarker of colorectal liver metastasis in future.

Entities:  

Keywords:  Colorectal cancer; DNA methylation; Epigenetics; MicroRNA

Mesh:

Substances:

Year:  2019        PMID: 30604369     DOI: 10.1007/s10620-018-5424-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.

Authors:  Matthias P A Ebert; Suzanne H Mooney; Lori Tonnes-Priddy; Joe Lograsso; Juliane Hoffmann; Jie Chen; Christoph Röcken; Hans-Ulrich Schulz; Peter Malfertheiner; Catherine Lofton-Day
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

Review 4.  The promise of epigenetic therapy: reprogramming the cancer epigenome.

Authors:  Andrew D Kelly; Jean-Pierre J Issa
Journal:  Curr Opin Genet Dev       Date:  2017-04-14       Impact factor: 5.578

Review 5.  Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility.

Authors:  Erine H Budi; Dana Duan; Rik Derynck
Journal:  Trends Cell Biol       Date:  2017-05-25       Impact factor: 20.808

6.  Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.

Authors:  Dong-Liang Chen; Zhi-Qiang Wang; Zhao-Lei Zeng; Wen-Jing Wu; Dong-Sheng Zhang; Hui-Yan Luo; Feng Wang; Miao-Zhen Qiu; De-Shen Wang; Chao Ren; Feng-Hua Wang; Lucia J Chiao; Helene Pelicano; Peng Huang; Yu-Hong Li; Rui-Hua Xu
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

7.  Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues.

Authors:  Amelie Lupp; Christoph Klenk; Christoph Röcken; Matthias Evert; Christian Mawrin; Stefan Schulz
Journal:  Eur J Endocrinol       Date:  2010-02-15       Impact factor: 6.664

Review 8.  Epigenetic plasticity and the hallmarks of cancer.

Authors:  William A Flavahan; Elizabeth Gaskell; Bradley E Bernstein
Journal:  Science       Date:  2017-07-21       Impact factor: 47.728

9.  miRWalk database for miRNA-target interactions.

Authors:  Harsh Dweep; Norbert Gretz; Carsten Sticht
Journal:  Methods Mol Biol       Date:  2014

Review 10.  The cancer epigenome: Concepts, challenges, and therapeutic opportunities.

Authors:  Mark A Dawson
Journal:  Science       Date:  2017-03-16       Impact factor: 63.714

View more
  13 in total

1.  Integration of gene expression data identifies key genes and pathways in colorectal cancer.

Authors:  Hossein Hozhabri; Ali Lashkari; Seyed-Morteza Razavi; Ali Mohammadian
Journal:  Med Oncol       Date:  2021-01-07       Impact factor: 3.064

2.  Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway.

Authors:  Hai Xie; Ren Jing; Xiaoting Liao; Haishao Chen; Xianlong Xie; Huijun Dai; Linghui Pan
Journal:  Hereditas       Date:  2022-07-14       Impact factor: 2.595

Review 3.  Noncoding RNA actions through IGFs and IGF binding proteins in cancer.

Authors:  Aidan Kerr; Robert C Baxter
Journal:  Oncogene       Date:  2022-05-21       Impact factor: 8.756

Review 4.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

5.  Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases.

Authors:  Chen Lu; Xiagang Luo; Cheng Xing; Yonghuan Mao; Yuting Xu; Wenjie Gao; Wulin Wang; Tian Zhan; Guoguang Wang; Zhengxia Liu; Chunzhao Yu
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

6.  miR-10b-5p Suppresses the Proliferation and Invasion of Primary Hepatic Carcinoma Cells by Downregulating EphA2.

Authors:  Xu Niu; Haitao Sun; Feng Qiu; Jing Liu; Tianchi Yang; Wei Han
Journal:  Biomed Res Int       Date:  2021-12-29       Impact factor: 3.411

7.  Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.

Authors:  Lian Zheng; Yang Yang; Xiaorong Cui
Journal:  Biomed Res Int       Date:  2021-11-08       Impact factor: 3.411

8.  Identification prognosis-associated immune genes in colon adenocarcinoma.

Authors:  Yandong Miao; Jiangtao Wang; Xueping Ma; Yuan Yang; Denghai Mi
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

9.  Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma.

Authors:  Zele Hu; Huigao Liu; Xinrong Zhang; Bin Hong; Zhenhua Wu; Qun Li; Chongchang Zhou
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

10.  Integrated bioinformatics identifies the dysregulation induced by aberrant gene methylation in colorectal carcinoma.

Authors:  Zhenyu Ye; Yecheng Li; Jiaming Xie; Zhenyu Feng; Xiaodong Yang; Yong Wu; Yuwei Pu; Jiawei Gao; Xiangrong Xu; Zhaobi Zhu; Wei Li; Wei Chen; Chungen Xing
Journal:  Genes Dis       Date:  2020-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.